AD/PD™ Session Spotlight
AD/PD™ 2026: Striving for a better future for all those affected by neurodegenerative diseases
AD/PD™ focuses on basic science and translational and clinical research to bring you:
New insights on disease mechanisms and etiologies.
The latest findings from clinical trials.
Innovative outlooks on therapy and prevention.
Advances in diagnostic markers.
Successful strategies to enhance collaboration.
A great opportunity to interact with peers and experts.
Abstract Submission
Submit your abstract and share your findings with our international community.
Cutting-Edge Science
The AD/PD™ Conference is where the brightest minds gather to explore the latest research, clinical trials, and treatments for Alzheimer's and Parkinson's. From uncovering groundbreaking discoveries to sharing the latest developments in treatments.
Top Speakers in the Field
The Conference will give you the amazing opportunity to meet and hear what the leading international experts are working on, discuss the latest news and trends in the field, and present in front of them your own work and gain valuable feedback.
AD/PD™ in Numbers
The AD/PD™ Conference has grown to be the leading event in the field of neurodegenerative disorders with over 5,500 participants from 70+ countries and over 2,500 abstracts submitted in 2025.
WHERE?
The Bella Center Copenhagen Denmark
AD/PD™ Education on UNLOK
The Online Community for all Neurodegenerative Disease Professionals